002755 奥赛康
已收盘 10-08 15:00:00
资讯
新帖
简况
奥赛康（002755）9月30日主力资金净买入7190.40万元
证券之星 · 10-08 09:01
奥赛康（002755）9月30日主力资金净买入7190.40万元
异动快报：奥赛康（002755）9月30日10点23分触及涨停板
证券之星 · 09-30
异动快报：奥赛康（002755）9月30日10点23分触及涨停板
奥赛康（002755）9月23日主力资金净卖出2820.22万元
证券之星 · 09-24
奥赛康（002755）9月23日主力资金净卖出2820.22万元
奥赛康：利厄替尼片两项适应症已纳入医保
证券之星 · 09-24
奥赛康：利厄替尼片两项适应症已纳入医保
研报掘金丨东海证券：首予奥赛康“买入”评级，业绩短期承压，研发快速推进
格隆汇 · 09-23
研报掘金丨东海证券：首予奥赛康“买入”评级，业绩短期承压，研发快速推进
异动快报：奥赛康（002755）9月21日14点5分触及涨停板
证券之星 · 09-21
异动快报：奥赛康（002755）9月21日14点5分触及涨停板
奥赛康(002755)9月10日股东户数3.33万户，较上期减少4.52%
证券之星 · 09-16
奥赛康(002755)9月10日股东户数3.33万户，较上期减少4.52%
奥赛康：截至9月10日，公司股东人数为33,305户
证券之星 · 09-16
奥赛康：截至9月10日，公司股东人数为33,305户
奥赛康(002755)8月31日股东户数3.49万户，较上期增加5.87%
证券之星 · 09-09
奥赛康(002755)8月31日股东户数3.49万户，较上期增加5.87%
股市必读：奥赛康新发布《第七届董事会第九次会议决议公告》
证券之星 · 08-28
股市必读：奥赛康新发布《第七届董事会第九次会议决议公告》
图解奥赛康中报：第二季度单季净利润同比下降65.64%
证券之星 · 08-28
图解奥赛康中报：第二季度单季净利润同比下降65.64%
奥赛康(002755.SZ)发布半年度业绩，归母净利润1.21亿元，同比减少24.6%
智通财经网 · 08-27
奥赛康(002755.SZ)发布半年度业绩，归母净利润1.21亿元，同比减少24.6%
奥赛康（002755）披露2026年半年度报告全文及摘要，8月27日股价上涨0.97%
证券之星 · 08-27
奥赛康（002755）披露2026年半年度报告全文及摘要，8月27日股价上涨0.97%
奥赛康披露2026年半年度报告：聚焦临床价值创造 积蓄创新发展势能
中国财富通 · 08-27
奥赛康披露2026年半年度报告：聚焦临床价值创造 积蓄创新发展势能
奥赛康(002755)8月20日股东户数3.29万户，较上期增加1.12%
证券之星 · 08-27
奥赛康(002755)8月20日股东户数3.29万户，较上期增加1.12%
股市必读：奥赛康(002755)股东户数3.26万户，较上期增加2.51%
证券之星 · 08-19
股市必读：奥赛康(002755)股东户数3.26万户，较上期增加2.51%
奥赛康：截至8月10日，公司股东人数为32,583户
证券之星 · 08-18
奥赛康：截至8月10日，公司股东人数为32,583户
股市必读：奥赛康(002755)股东户数3.18万户，较上期增加0.11%
证券之星 · 08-07
股市必读：奥赛康(002755)股东户数3.18万户，较上期增加0.11%
奥赛康：截至7月31日，公司股东人数为31,786户
证券之星 · 08-06
奥赛康：截至7月31日，公司股东人数为31,786户
公司问答丨奥赛康：麦芽酚铁胶囊上市申请于今年3月获受理 目前处于审评阶段
格隆汇 · 07-24
公司问答丨奥赛康：麦芽酚铁胶囊上市申请于今年3月获受理 目前处于审评阶段
暂无数据
公司概况
公司名称：
北京奥赛康药业股份有限公司
所属行业：
医药制造业
上市日期：
2015-05-15
主营业务：
北京奥赛康药业股份有限公司的主营业务是原料药及制剂的研发、生产、销售。公司的主要产品是消化类、抗肿瘤类、抗感染类、慢性病类。公司11件主导产品核心专利技术分别荣获中国专利金奖1项、省专利项目奖金奖1项、省专利项目奖优秀奖3项、市优秀专利奖6项。
发行价格：
7.49
{"stockData":{"symbol":"002755","market":"SZ","secType":"STK","nameCN":"奥赛康","latestPrice":13.22,"timestamp":1791442992000,"preClose":13.55,"halted":0,"volume":24790591,"delay":0,"changeRate":-0.0244,"floatShares":927999999,"shares":927999999,"eps":0.2126,"marketStatus":"已收盘","change":-0.33,"latestTime":"10-08 15:00:00","open":13.82,"high":13.95,"low":13.07,"amount":331000000,"amplitude":0.0649,"askPrice":13.22,"askSize":16,"bidPrice":13.21,"bidSize":324,"shortable":0,"etf":0,"ttmEps":0.2126,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":5,"adr":0,"adjPreClose":13.55,"symbolType":"stock","openAndCloseTimeList":[[1791423000000,1791430200000],[1791435600000,1791442800000]],"highLimit":14.91,"lowLimit":12.2,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":928160351,"isCdr":false,"pbRate":3.9,"roa":"--","peRate":62.182502,"roe":"3.81%","epsLYR":0.25,"committee":0.552291,"marketValue":12270000000,"turnoverRate":0.0267,"status":1,"floatMarketCap":12270000000},"requestUrl":"/m/hq/s/002755/tweets","defaultTab":"tweets","newsList":[{"id":"2673049407","title":"奥赛康（002755）9月30日主力资金净买入7190.40万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673049407?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:01","pubTimestamp":1791421306,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，奥赛康报收于13.55元，上涨9.98%，涨停，换手率2.03%，成交量18.85万手，成交额2.48亿元。9月30日的资金流向数据方面，主力资金净流入7190.4万元，占总成交额28.94%，游资资金净流出3323.36万元，占总成交额13.38%，散户资金净流出3867.04万元，占总成交额15.56%。近5日资金流向一览见下表：奥赛康融资融券信息显示，融资方面，当日融资买入654.23万元，融资偿还1636.43万元，融资净偿还982.2万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800002842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671322106","title":"异动快报：奥赛康（002755）9月30日10点23分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2671322106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671322106?lang=zh_cn&edition=full","pubTime":"2026-09-30 10:25","pubTimestamp":1790735131,"startTime":"0","endTime":"0","summary":"证券之星9月30日盘中消息，10点23分奥赛康（002755）触及涨停板。其所属行业化学制药目前上涨。领涨股为键凯科技。该股为创新药，幽门螺杆菌概念，医药概念热股，当日创新药概念上涨2.76%，幽门螺杆菌概念概念上涨2.54%，医药概念上涨2.53%。9月29日的资金流向数据方面，主力资金净流出545.37万元，占总成交额5.69%，游资资金净流出51.24万元，占总成交额0.53%，散户资金净流入596.61万元，占总成交额6.22%。近5日资金流向一览见下表：奥赛康主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000011510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669430779","title":"奥赛康（002755）9月23日主力资金净卖出2820.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669430779","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669430779?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:20","pubTimestamp":1790212828,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，奥赛康报收于12.97元，下跌3.14%，换手率2.36%，成交量21.86万手，成交额2.86亿元。9月23日的资金流向数据方面，主力资金净流出2820.22万元，占总成交额9.86%，游资资金净流出3600.33万元，占总成交额12.58%，散户资金净流入6420.55万元，占总成交额22.44%。近5日资金流向一览见下表：奥赛康融资融券信息显示，融资方面，当日融资买入1819.56万元，融资偿还1781.87万元，融资净买入37.69万元，连续3日净买入累计638.84万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400009257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002755","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669430350","title":"奥赛康：利厄替尼片两项适应症已纳入医保","url":"https://stock-news.laohu8.com/highlight/detail?id=2669430350","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669430350?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:01","pubTimestamp":1790211679,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康(002755)09月23日在投资者关系平台上答复投资者关心的问题。投资者提问：＂请问利厄替尼片2026H1销售收入是多少？进院进度如何？＂奥赛康回复：您好，利厄替尼片两项适应症已纳入医保，并于2026年1月1日起正式执行，依托国家创新药支持政策，公司持续推进终端覆盖，院内和双通道药房销售工作有序开展，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400008773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669108803","title":"研报掘金丨东海证券：首予奥赛康“买入”评级，业绩短期承压，研发快速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2669108803","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669108803?lang=zh_cn&edition=full","pubTime":"2026-09-23 14:23","pubTimestamp":1790144630,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0028","161027","BK0239","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669130419","title":"异动快报：奥赛康（002755）9月21日14点5分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2669130419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669130419?lang=zh_cn&edition=full","pubTime":"2026-09-21 14:10","pubTimestamp":1789971053,"startTime":"0","endTime":"0","summary":"证券之星9月21日盘中消息，14点5分奥赛康（002755）触及涨停板。其所属行业化学制药目前上涨。领涨股为华仁药业。该股为创新药，医药，幽门螺杆菌概念概念热股，当日创新药概念上涨4.28%，医药概念上涨3.88%，幽门螺杆菌概念概念上涨3.71%。9月18日的资金流向数据方面，主力资金净流入999.06万元，占总成交额9.07%，游资资金净流出230.18万元，占总成交额2.09%，散户资金净流出768.88万元，占总成交额6.98%。近5日资金流向一览见下表：奥赛康主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100013211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002755","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667601058","title":"奥赛康(002755)9月10日股东户数3.33万户，较上期减少4.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667601058","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667601058?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:37","pubTimestamp":1789551450,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年9月10日公司股东户数为3.33万户，较8月31日减少1577.0户，减幅为4.52%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至9月10日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年8月31日至2026年9月10日，奥赛康区间涨幅为2.2%，在此期间股东户数减少1577.0户，减幅为4.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600027852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667608241","title":"奥赛康：截至9月10日，公司股东人数为33,305户","url":"https://stock-news.laohu8.com/highlight/detail?id=2667608241","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667608241?lang=zh_cn&edition=full","pubTime":"2026-09-16 15:07","pubTimestamp":1789542441,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康(002755)09月15日在投资者关系平台上答复投资者关心的问题。投资者提问：截止9.10日贵司持股户数有多少？奥赛康回复：您好，截至9月10日，公司股东人数为33,305户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600018767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666058905","title":"奥赛康(002755)8月31日股东户数3.49万户，较上期增加5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666058905","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666058905?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:28","pubTimestamp":1788946085,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年8月31日公司股东户数为3.49万户，较8月20日增加1935.0户，增幅为5.87%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至8月31日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年8月20日至2026年8月31日，奥赛康区间跌幅为18.71%，在此期间股东户数增加1935.0户，增幅为5.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900029369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002755","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662244035","title":"股市必读：奥赛康新发布《第七届董事会第九次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662244035","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662244035?lang=zh_cn&edition=full","pubTime":"2026-08-28 05:21","pubTimestamp":1787865675,"startTime":"0","endTime":"0","summary":"股本股东变化：截至2026年8月20日，奥赛康股东户数为3.29万户，较8月10日增长1.12%。公司公告汇总：奥赛康于2026年8月27日召开第七届董事会第九次会议，审议通过《关于公司2026年半年度报告全文及摘要的议案》。股本股东变化股东户数变动截至2026年8月20日，奥赛康股东户数为3.29万户，较8月10日增加364.0户，增幅为1.12%；户均持股数量由2.85万股减少至2.82万股，户均持股市值为39.44万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800009688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662087940","title":"图解奥赛康中报：第二季度单季净利润同比下降65.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662087940","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662087940?lang=zh_cn&edition=full","pubTime":"2026-08-28 02:28","pubTimestamp":1787855296,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康2026年中报显示，上半年度公司主营收入8.71亿元，同比下降13.54%；归母净利润1.21亿元，同比下降24.6%；扣非净利润1.07亿元，同比下降24.44%；其中2026年第二季度，公司单季度主营收入3.89亿元，同比下降21.97%；单季度归母净利润3616.43万元，同比下降65.64%；单季度扣非净利润2960.67万元，同比下降69.47%；负债率24.9%，投资收益266.55万元，财务费用-619.94万元，毛利率82.05%。财报数据概要请见下图:本文数据来源于奥赛康2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800005979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662894630","title":"奥赛康(002755.SZ)发布半年度业绩，归母净利润1.21亿元，同比减少24.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662894630","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662894630?lang=zh_cn&edition=full","pubTime":"2026-08-27 23:16","pubTimestamp":1787843788,"startTime":"0","endTime":"0","summary":"智通财经APP讯，奥赛康 发布2026年半年度报告，报告期内，公司实现营业收入8.71亿元，同比减少13.54%;实现归属于上市公司股东的净利润1.21亿元，同比减少24.6%;实现归属于上市公司股东的扣除非经常性损益的净利润1.07亿元，同比减少24.44%;基本每股收益0.13元。报告期内，公司持续加大对创新药的研发投入，报告期内研发费用较上年同期增加62.58%，导致报告期内公司净利润较上年同期有所减少。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487560.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"奥赛康(002755.SZ)发布半年度业绩，归母净利润1.21亿元，同比减少24.6%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662779085","title":"奥赛康（002755）披露2026年半年度报告全文及摘要，8月27日股价上涨0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662779085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662779085?lang=zh_cn&edition=full","pubTime":"2026-08-27 22:21","pubTimestamp":1787840476,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，奥赛康报收于12.53元，较前一交易日上涨0.97%，最新总市值为116.3亿元。该股当日开盘12.43元，最高12.63元，最低12.23元，成交额达1.21亿元，换手率为1.05%。近日，北京奥赛康药业股份有限公司召开第七届董事会第九次会议，审议通过《关于公司2026年半年度报告全文及摘要的议案》。会议应到董事9人，实到9人，表决结果为9票同意，0票反对，0票弃权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700055562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662707012","title":"奥赛康披露2026年半年度报告：聚焦临床价值创造 积蓄创新发展势能","url":"https://stock-news.laohu8.com/highlight/detail?id=2662707012","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662707012?lang=zh_cn&edition=full","pubTime":"2026-08-27 20:22","pubTimestamp":1787833340,"startTime":"0","endTime":"0","summary":"8月27日晚间，北京奥赛康药业股份有限公司披露2026年半年度报告。此外，利厄替尼片两项适应症自2026年1月1日起正式执行国家医保目录支付标准。在创新研发方面，奥赛康坚持自主研发与引进合作双向发力，重点聚焦小分子靶向创新药和肿瘤免疫生物创新药。2026年上半年，奥赛康秉持“研究为源，健康为本”的企业理念，以临床价值为导向，统筹推进各项研发与经营工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=aUxwWX1S1qg%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0239","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270396","title":"奥赛康(002755)8月20日股东户数3.29万户，较上期增加1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270396","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662270396?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:10","pubTimestamp":1787825452,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年8月20日公司股东户数为3.29万户，较8月10日增加364.0户，增幅为1.12%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至8月20日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年8月10日至2026年8月20日，奥赛康区间涨幅为1.45%，在此期间股东户数增加364.0户，增幅为1.12%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491972","title":"股市必读：奥赛康(002755)股东户数3.26万户，较上期增加2.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491972","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660491972?lang=zh_cn&edition=full","pubTime":"2026-08-19 02:40","pubTimestamp":1787078425,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘，奥赛康报收于13.45元，下跌1.97%，换手率0.9%，成交量8.36万手，成交额1.13亿元。当日关注点交易信息汇总：8月18日主力资金净流出258.45万元，占总成交额2.29%。股本股东变化：截至2026年8月10日，奥赛康股东户数为3.26万户，较7月31日增加797户，增幅2.51%。董秘最新回复投资者： 您好！请问截至8月10日公司股东人数是多少，谢谢董秘： 您好，截至8月10日，公司股东人数为32,583户，感谢您对公司的关注！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453755","title":"奥赛康：截至8月10日，公司股东人数为32,583户","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453755","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660453755?lang=zh_cn&edition=full","pubTime":"2026-08-18 09:12","pubTimestamp":1787015534,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康(002755)08月18日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至8月10日公司股东人数是多少，谢谢奥赛康回复：您好，截至8月10日，公司股东人数为32,583户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800008407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657597446","title":"股市必读：奥赛康(002755)股东户数3.18万户，较上期增加0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657597446","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657597446?lang=zh_cn&edition=full","pubTime":"2026-08-07 01:39","pubTimestamp":1786037951,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，奥赛康报收于13.16元，下跌1.28%，换手率0.84%，成交量7.77万手，成交额1.02亿元。当日关注点交易信息汇总：8月6日主力资金净流入498.19万元，占总成交额4.86%。股本股东变化：截至2026年7月31日，奥赛康股东户数为3.18万户，较7月10日增加34.0户，增幅0.11%。户均持股数量由上期的2.92万股减少至2.92万股，户均持股市值为38.08万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002755","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657807506","title":"奥赛康：截至7月31日，公司股东人数为31,786户","url":"https://stock-news.laohu8.com/highlight/detail?id=2657807506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657807506?lang=zh_cn&edition=full","pubTime":"2026-08-06 11:37","pubTimestamp":1785987452,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康(002755)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到7月31日公司股东人数是多少？谢谢奥赛康回复：您好，截至7月31日，公司股东人数为31,786户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600015609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653570409","title":"公司问答丨奥赛康：麦芽酚铁胶囊上市申请于今年3月获受理 目前处于审评阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2653570409","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653570409?lang=zh_cn&edition=full","pubTime":"2026-07-24 15:38","pubTimestamp":1784878689,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","BK0028","002755"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791495846224,"stockEarnings":[{"period":"1week","weight":-0.0244},{"period":"1month","weight":0.0872},{"period":"3month","weight":-0.1037},{"period":"6month","weight":-0.1527},{"period":"1year","weight":-0.3562},{"period":"ytd","weight":-0.1827}],"compareEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":-0.0326},{"period":"3month","weight":-0.0461},{"period":"6month","weight":-0.0437},{"period":"1year","weight":-0.0183},{"period":"ytd","weight":-0.0395}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京奥赛康药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"33703人(较上一季度增加1.20%)","perCapita":"27539股","listingDate":"2015-05-15","address":"北京市丰台区南四环西路188号七区28号楼","registeredCapital":"92816万元","survey":" 北京奥赛康药业股份有限公司的主营业务是原料药及制剂的研发、生产、销售。公司的主要产品是消化类、抗肿瘤类、抗感染类、慢性病类。公司11件主导产品核心专利技术分别荣获中国专利金奖1项、省专利项目奖金奖1项、省专利项目奖优秀奖3项、市优秀专利奖6项。","listedPrice":7.49},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥赛康(002755)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥赛康,002755,奥赛康股票,奥赛康股票老虎,奥赛康股票老虎国际,奥赛康行情,奥赛康股票行情,奥赛康股价,奥赛康股市,奥赛康股票价格,奥赛康股票交易,奥赛康股票购买,奥赛康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥赛康(002755)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}